Trial Profile
Clinical evaluation of GSK576428 (fondaparinux sodium) in prevention of venous thromboembolism (VTE) after abdominal surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Aug 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by ClinicalTrials.gov.
- 29 Sep 2006 New trial record.